These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1649576)

  • 81. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
    AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
    Sheehy N; Desselberger U
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Resistance to azidothymidine in human immunodeficiency virus (HIV) infection].
    Karmanov EV; Lukashov VV
    Mol Biol (Mosk); 1994; 28(1):7-20. PubMed ID: 7511784
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.
    Smith MS; Kessler JA; Rankin CD; Pagano JS; Kurtzberg J; Carter SG
    Antimicrob Agents Chemother; 1993 Jan; 37(1):144-7. PubMed ID: 8431013
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay.
    Larder BA; Chesebro B; Richman DD
    Antimicrob Agents Chemother; 1990 Mar; 34(3):436-41. PubMed ID: 2334156
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
    Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
    Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.
    Tachedjian G; Mellors J; Bazmi H; Birch C; Mills J
    J Virol; 1996 Oct; 70(10):7171-81. PubMed ID: 8794364
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
    Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
    J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
    Brehm JH; Koontz D; Meteer JD; Pathak V; Sluis-Cremer N; Mellors JW
    J Virol; 2007 Aug; 81(15):7852-9. PubMed ID: 17507476
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.
    Eron JJ; Gorczyca P; Kaplan JC; D'Aquila RT
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3241-5. PubMed ID: 1565615
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1.
    García-Lerma JG; Gerrish PJ; Wright AC; Qari SH; Heneine W
    J Virol; 2000 Oct; 74(20):9339-46. PubMed ID: 11000201
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera.
    Albert J; Wahlberg J; Lundeberg J; Cox S; Sandström E; Wahren B; Uhlén M
    J Virol; 1992 Sep; 66(9):5627-30. PubMed ID: 1380098
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Biochemical and genetical analysis of AZT-resistant HIV-mutants.
    Biesert L; Zimmermann F; Schröder B; Matthes E; Suhartono H; Dietrich U; Rübsamen-Waigmann H
    Behring Inst Mitt; 1991 Jul; (89):74-80. PubMed ID: 1930105
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol.
    Heredia A; Davis C; Redfield R
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):246-55. PubMed ID: 11115955
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidine.
    Hostetler KY; Richman DD; Carson DA; Stuhmiller LM; van Wijk GM; van den Bosch H
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2025-9. PubMed ID: 1416896
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
    Gao WY; Shirasaka T; Johns DG; Broder S; Mitsuya H
    J Clin Invest; 1993 May; 91(5):2326-33. PubMed ID: 8387546
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein.
    Erice A; Balfour HH; Myers DE; Leske VL; Sannerud KJ; Kuebelbeck V; Irvin JD; Uckun FM
    Antimicrob Agents Chemother; 1993 Apr; 37(4):835-8. PubMed ID: 8494381
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.
    Japour AJ; Mayers DL; Johnson VA; Kuritzkes DR; Beckett LA; Arduino JM; Lane J; Black RJ; Reichelderfer PS; D'Aquila RT
    Antimicrob Agents Chemother; 1993 May; 37(5):1095-101. PubMed ID: 8517697
    [TBL] [Abstract][Full Text] [Related]  

  • 100. In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus.
    Inoue T; Tsushita K; Itoh T; Ogura M; Hotta T; Saneyoshi M; Yoshida S; Saitoh H; Tomoda Y; Nagai Y
    Antimicrob Agents Chemother; 1989 Apr; 33(4):576-9. PubMed ID: 2543285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.